Oncotarget

Brief Reports:

A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis

Jon H. Chung and Fred Bunz _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2013; 4:2208-2211. https://doi.org/10.18632/oncotarget.1651

Metrics: PDF 1787 views  |   HTML 1916 views  |   ?  


Abstract

Jon H. Chung1 and Fred Bunz1

1 Department of Radiation Oncology and Molecular Radiation Sciences, The Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, USA

Correspondence:

Fred Bunz, email:

Keywords: Hedgehog, colorectal cancer, Patched, vismodegib, autocrine

Received: December 3, 2013 Accepted: December 9, 2013 Published: December 11, 2013

Abstract

Hedgehog (Hh) signaling is largely suppressed in the normal differentiated tissues of the adult but activated in many cancers. The Hh pathway can either be activated by the expression of Hh ligands, or by mutations that cause constitutive, ligand-independent signaling. Colorectal cancer cells frequently express Hh ligands that are believed to exert paracrine effects on the stromal component of the tumor. Evidence for a more direct role of Hh signaling on the growth and evolution of colorectal cancer cell clones has been lacking. Here, we report a loss-of-function mutation of PTCH1, a tumor suppressor in the Hh pathway, in a colorectal cancer that exhibits transcriptional upregulation of the downstream Hh gene GLI1. This finding demonstrates that autocrine Hh signaling can provide a selective advantage to evolving tumors that arise in the colorectal epithelia, and suggests a definable group of colorectal cancer patients that could derive enhanced benefit from Hh pathway inhibitors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 1651